欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2006, Vol. 11 ›› Issue (2): 145-152.

• 研究原著 • 上一篇    下一篇

CPU0213 通过抑制 ET 系统和 NF-κB 通路 改善感染性休克大鼠血管活性

贺海波 ,袁盛华 ,戴德哉 ,吉民1   

  1. 中国药科大学药理学研究室, 南京 210009 ,江苏;1东南大学药学化学系, 南京 210009 , 江苏
  • 收稿日期:2005-11-30 修回日期:2006-01-05 出版日期:2006-02-06 发布日期:2020-10-26
  • 通讯作者: 戴德哉, 通讯作者, 男, 教授, 博士生导师, 研究方向:心血管药理学。 Tel:025-83271270 E-mail:dezaidai@vip.sina .com E-mail:dezaidai@vip.sina .com
  • 作者简介:贺海波, 男, 博士研究生, 研究方向:心血管药理学。 Tel:025-83271453 E-mail:hjy219@126.com 戴德哉, 通讯作者, 男, 教授, 博士生导师, 研究方向:心血管药理学。 Tel:025-83271270 E-mail:dezaidai@vip.sina .com
  • 基金资助:
    国家自然科学基金重点项目(№30230170);国家自然科学基金项目 (№30171078)

CPU0213 ameliorates vascular activity of septic shock rats by suppressing ET system and NF-κB pathway

HE Hai-bo , YUAN Sheng-hua , DAI De-zai , JI Min1   

  1. Research Division of Pharmacology , China Pharmaceutical University , Nanjing 210009 , Jiangsu ,China ;1Department of Pharmaceutical Chemistry , South-East University , Nanjing 210009 , Jiangsu , China
  • Received:2005-11-30 Revised:2006-01-05 Online:2006-02-06 Published:2020-10-26

摘要: 目的 :通过观察 CPU0213 对感染性休克大鼠 血管活性的改善 ,探讨其治疗感染性休克可能的作 用机制。方法:感染性休克大鼠术后 8 h 皮下给予 CPU0213(30 mg·kg -1 , bid ×3 d)。记录存活率, 血流 动力学参数,器官脏器系数和腹腔渗出液重量 ,检测 血浆 ET-1 和血清 iNOS 、GSH-PX 、SOD 、MDA 含量及 胸主动脉血管活性 ,肠系膜血管 NF-κB 、TNF-α、iNOS 和ET 系统mRNA 表达及其激活态NF-κB 蛋白表达 。 结果 :模型组大鼠存活率和平均动脉压明显降低, 心 率和器官脏器系数明显增加, 腹腔渗出液显著增多 , ET-1 和 iNOS 、MDA 含量明显增加, GSH-PX 和 SOD 活性显著下降, 血管功能明显降低, TNF-α、iNOS 和 ET 系统 mRNA 表达及 NF-κB 的蛋白表达明显增加 ; CPU0213 治疗后, 上述指标均有不同程度改善 。结 论:CPU0213 通过阻断 ET 系统和NF-κB 通路改善血 管活性,减少腹腔渗出液 ,提高存活率。

关键词: CPU0213 , 感染性休克, 内皮素, 内皮素受 体拮抗剂 , 血管活性 , 基因和蛋白表达

Abstract: AIM:To study the amelioration of blood vessel and mechanism of a non-selective ETA ETB receptor antagonist (CPU0213)on cecal ligation and puncture (CLP)rats .METHODS :After 8 hours at CLP , the rats were subcutaneouly administered with CPU0213 (30 mg·kg -1 , bid ×3 d).During the time , the changes of survival, hemodynamic parameter (mean arterial pres- sure :MAP, HR :heart rate), indexes of important or- gans and weight of peritoneal exudates were reviewed , plasma ET-1 and serum iNOS , GSH-PX , SOD , MDA were detected , simultaneously , the activity of aorta pecto- ralis and was registered , the mRNA expressions of NF- κB , TNF-α, iNOS , ECE (endothelin converting enzyme), preproET-1 , ETA , ETB receptor and the activated NF-κB protein amount of mesenteric blood vessel were detected . RESULTS:In the septic model group , the MAP and survival rate decreased (P <0 .01);the HR , indexes of important organs and weight of peritoneal exudates were increased significantly (P <0 .01);blood vessel activity of aorta pectoralis (in vivo and in vitro)were decreased ; The levels of ET-1 , iNOS and ROS in serum were mark- edly increased (P <0 .01);the mRNA levels of TNF-α, iNOS , preproET-1 , ECE , ETA R and ETBR in mesenteric blood vessel were enhanced significantly (P <0 .01);the protein amount of activated NF-κB was increased (P < 0 .01)versus sham-operated group .All of these changes were reversed after CPU0213 administration .CONCLU- SION:CPU0213 can lessen the impairment of vascular smooth muscle cell, decrease effusion , recover vascular normal activity , degrade indexes of organs, and elevate survival rate by suppressing the ET system and NF-κB pathway .

Key words: CPU0213 , septic shock , endothelin re- ceptor antagonist , vascular activity , gene and protein ex- pression

中图分类号: